These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 2166084)

  • 1. Immunologic abnormalities in chronic fatigue syndrome.
    Klimas NG; Salvato FR; Morgan R; Fletcher MA
    J Clin Microbiol; 1990 Jun; 28(6):1403-10. PubMed ID: 2166084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
    Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J
    J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
    Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG
    PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
    PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic abnormalities associated with chronic fatigue syndrome.
    Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S136-41. PubMed ID: 8148441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive immunological analysis in chronic fatigue syndrome.
    Gupta S; Vayuvegula B
    Scand J Immunol; 1991 Mar; 33(3):319-27. PubMed ID: 1849315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence.
    Vuillier F; Scott-Algara D; Dighiero G
    Nouv Rev Fr Hematol (1978); 1991; 33(1):31-8. PubMed ID: 1682878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy.
    Matthiesen L; Berg G; Ernerudh J; Håkansson L
    Am J Reprod Immunol; 1996 Feb; 35(2):70-9. PubMed ID: 8839133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL; Palencia T; Fernández G; García M
    Front Immunol; 2018; 9():1028. PubMed ID: 29867995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte phenotype and function in the chronic fatigue syndrome.
    Straus SE; Fritz S; Dale JK; Gould B; Strober W
    J Clin Immunol; 1993 Jan; 13(1):30-40. PubMed ID: 8095270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome.
    Morrison LJ; Behan WH; Behan PO
    Clin Exp Immunol; 1991 Mar; 83(3):441-6. PubMed ID: 1706238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
    Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.
    Peakman M; Deale A; Field R; Mahalingam M; Wessely S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):83-91. PubMed ID: 9000046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.